Evidence map›Paper›PMID 41971927›Full record

ArticleAME case reports2026

Infected pseudotumor following metal-on-metal total hip arthroplasty: a case report with diagnostic challenges and implications for surveillance guidelines.

Aymen Zgolli, Hichem Issaoui, Fredson Razanabola, Guillaume Odri

Abstract readCase Reports
In one paragraph

Article in AME case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Aymen ZgolliDepartment of Orthopedic Surgery, Rambouillet Hospital, Rambouillet, France.ORCID https://orcid.org/0000-0003-3088-9616
Hichem IssaouiDepartment of Orthopedic Surgery, Orleans University Hospital, Orleans, France.
Fredson RazanabolaDepartment of Orthopedic Surgery, Orleans University Hospital, Orleans, France.
Guillaume OdriDepartment of Orthopedic Surgery, Orleans University Hospital, Orleans, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Adverse reaction to metal debris (ARMD) includes metallosis, aseptic lymphocytic vasculitis-associated lesion (ALVAL), and pseudotumors. ARMD is rare and has many clinical presentations that can be confusing. It is the cause of 0.6% of total hip arthroplasty (THA) failures, considering all types of bearing couples, and the most frequent cause of metal-on-metal (MoM) THA failures. The main reasons for revisions related to ARMD are ALVAL and pseudotumor. Patients with MoM THA are at higher risk of developing periprosthetic joint infection (PJI). Those two complications are confusing. Case Description: We report a case of an undiagnosed specific complication in a patient with a MoM THA who presented in 2023 with an acute PJI. Imaging revealed an infected pelvic cyst. After reviewing previous scans, we concluded that the cyst was a metal-induced pseudotumor that had been present since 2019 but had been neglected. The pseudotumor was compressing the iliac vein, which explains a history of deep venous thrombosis (DVT) and lymphedema, previously and incorrectly attributed to prostatic adenocarcinoma. The patient underwent a two-stage revision; unfortunately, he died 32 days later. Conclusions: MoM THA require careful and regulated follow-up. We must pay closer attention to this specific and misleading complication, so we summarized monitoring guideline to make it clearer.

Indexed as

adverse reaction to metal debris (ARMD)aseptic lymphocytic vasculitis-associated lesion (ALVAL)Case reporthip arthroplastyperiprosthetic joint infection (PJI)

Identifiers

PMID41971927
PMCPMC13062803

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.